Keya Medical
AI for Smarter Healthcare
Keya Medical Raises $46M in Series D Round.
About
Keya Medical is a medical technology manufacturer developing AI solutions that enable healthcare delivery organizations to provide better patient care.
Since 2016, the company has combined advanced deep learning algorithms with other technologies to provide accurate diagnosis and treatment solutions to medical institutions around the world.
Today, Keya Medical has partnered with over 200 healthcare systems around the world, and the company’s products are used widely in hospitals throughout Asia.
DeepVessel FFR
DeepVessel FFR* uses deep learning technology to perform a non-invasive physiological functional assessment of the coronary arteries using coronary CT angiogram scans. The software reduces unnecessary invasive testing to lower costs and complications.
*CE Marked, National Medical Products Administration (NMPA) Approved. Not for sale in the United States.
DeepVessel FFR Approved for Clinical Use in China
On January 15, 2020, the National Medical Products Administration (NMPA) in China issued the registration certificate approving DeepVessel FFR for clinical use.
CuraRad® – ICH
Who do we work with
Healthcare Delivery
Keya Medical is committed to developing medical imaging AI solutions in collaboration with healthcare providers. Since 2016, we have worked with more than 200 hospitals around the world.
Payers
Keya Medical is continuing to develop new solutions to improve cardiovascular disease diagnosis and treatment. We invite payers to continue the conversation on how our solutions can create savings.
Investors
Keya Medical is funded by visionary investors who want to make a positive social impact and benefit from the potential expansion of medical AI.
Latest News
The Value of Deep Learning-based CT-FFR in Detecting Coronary Stenosis & Predicting Outcomes
Researchers at Fuwai Hospital conducted a retrospective study to evaluate the performance of Keya Medical’s deep learning-based CT-FFR product in detecting hemodynamic changes in stenosis.
Putting the Spotlight on Women’s Hearts: Cardiovascular Disease in Women
Cardiovascular disease (CVD) remains the leading cause of death for women in the U.S. In honor of American Heart Month, we are highlighting the differences in women’s risk factors and primary prevention to help manage CVD in women.
Will New Value-based Care Regulations Spark Innovation?
On Jan. 19, two regulatory changes went into effect that intend to modernize the Physician Self-Referral Statute & the Anti-Kickback Statute, facilitating the shift to value-based care.
